Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Trinh Kieu, Dinh"'
Autor:
Cheng-Ru Wu, Yi-Da Huang, Yong-Huei Hong, Ya-Hsin Liu, Manmath Narwane, Yu-Hsiang Chang, Trinh Kieu Dinh, Hsin-Tzu Hsieh, Yi-Jen Hseuh, Ping-Ching Wu, Chih-Wen Pao, Ting-Shan Chan, I-Jui Hsu, Yunching Chen, Hung-Chi Chen, Ting-Yu Chin, Tsai-Te Lu
Publikováno v:
JACS Au, Vol 1, Iss 7, Pp 998-1013 (2021)
Externí odkaz:
https://doaj.org/article/ddb4c49c3a7a4208ad4b7b0866cf72c1
Autor:
Hung-Hsun Lu, Hsueh Wen Liu, Trinh Kieu Dinh, Cheng-Hung Huang, Hsi-Chien Huang, Ya-Ching Tseng, Man-Hsuan Ku, Fu-Sheng Wang, Yunching Chen, Chi-How Peng
Publikováno v:
Polymer Chemistry. 13:5568-5578
Triblock copolymer, PEG-b-PDMAEMA-b-PDPA, simultaneously encapsulated doxorubicin and Bcl-2 siRNA for delivery to cancer cells, thus achieving combination chemotherapy and gene therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab273c80dd5330f1a93243af25944ff7
https://doi.org/10.1039/d2py00246a
https://doi.org/10.1039/d2py00246a
Autor:
Tsai-Te Lu, Yi-Da Huang, Hung-Chi Chen, Ting-Yu Chin, I-Jui Hsu, Yi-Jen Hseuh, Hsin-Tzu Hsieh, Cheng-Ru Wu, Trinh Kieu Dinh, Chih-Wen Pao, Yong-Huei Hong, Ting-Shan Chan, Ping-Ching Wu, Manmath Narwane, Ya-Hsin Liu, Yunching Chen, Yu-Hsiang Chang
Publikováno v:
JACS Au, Vol 1, Iss 7, Pp 998-1013 (2021)
JACS Au
JACS Au
Nitric oxide (NO), a pro-neurogenic and antineuroinflammatory gasotransmitter, features the potential to develop a translational medicine against neuropathological conditions. Despite the extensive efforts made on the controlled delivery of therapeut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582812bc1c855c625cd63b399c5a34ea
https://doi.org/10.1021/jacsau.1c00160
https://doi.org/10.1021/jacsau.1c00160
Autor:
Jane Wang, Fu Nien Wang, Yunching Chen, Yi-An Lee, Chih-Chun Chang, Trinh Kieu Dinh, Yi-Da Huang, Dehui Wan, Yu-Chuan Shih, Tsai-Te Lu, Yun-Chieh Sung, Pei-Lun Yu, Shao-Chieh Chiu, Cheng-Yun Wu
Publikováno v:
ACS Applied Materials & Interfaces. 12:44407-44419
Antiangiogenic therapy is widely administered in many cancers, and the antiangiogenic drug sorafenib offers moderate benefits in advanced hepatocellular carcinoma (HCC). However, antiangiogenic therapy can also lead to hypoxia-driven angiogenesis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d5c7e479927d0b0cad6b36d02720dfe
https://doi.org/10.1021/acsami.0c08473
https://doi.org/10.1021/acsami.0c08473
Autor:
Yi-Yu Ke, Ming-Chen Chou, Jiing-Jyh Jan, Trinh Kieu Dinh, Chien-Huang Wu, Chia-Jui Lee, Kai-Chia Yeh, Jing-Kai Huang, Yen-Nhi Ngoc Ta, Kuan-Wei Huang, Kak-Shan Shia, Jen-Shin Song, Yun-Chieh Sung, Chih-Chun Chang, Teng-Kuang Yeh, Ting-Yun Shiue, Yunching Chen
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance A highly selective, safe, and potent CXCR4 antagonist, BPRCX807, has been designed and experimentally validated in various hepatocellular carcinoma models. Through combination therapy, it can synergize with either a kinase (e.g., sorafen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb5b594bec713b18d964bcc9a233a691
https://pubmed.ncbi.nlm.nih.gov/33753481
https://pubmed.ncbi.nlm.nih.gov/33753481
Autor:
Chih-Chun, Chang, Trinh Kieu, Dinh, Yi-An, Lee, Fu-Nien, Wang, Yun-Chieh, Sung, Pei-Lun, Yu, Shao-Chieh, Chiu, Yu-Chuan, Shih, Cheng-Yun, Wu, Yi-Da, Huang, Jane, Wang, Tsai-Te, Lu, Dehui, Wan, Yunching, Chen
Publikováno v:
ACS applied materialsinterfaces. 12(40)
Antiangiogenic therapy is widely administered in many cancers, and the antiangiogenic drug sorafenib offers moderate benefits in advanced hepatocellular carcinoma (HCC). However, antiangiogenic therapy can also lead to hypoxia-driven angiogenesis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2e658c12ed271c0130781193bb2581a6
https://pubmed.ncbi.nlm.nih.gov/32865389
https://pubmed.ncbi.nlm.nih.gov/32865389
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fu Fei Hsu, Chu Chi Lin, Cheng Chin Chiang, Yunching Chen, Yu-Ting Huang, Chih-Chun Chang, Jiantai Timothy Qiu, Hsi Chien Huang, Trinh Kieu Dinh, Guann Jen Chern, Yun Chieh Sung, Kuan Wei Huang, Rui Lin Huang, Yi An Lee, Yung-Chang Lin, Shu-Yi Lin, Donia Alson, Chun-Yen Lin, Yu Chuan Shih, Po Chiao Chang
Publikováno v:
Science Advances
The dual-targeted immunogene therapy that inhibits PD-L1 and provides IL-2 can enhance the therapeutic efficacy of cancer vaccine.
While immunotherapy holds great promise for combating cancer, the limited efficacy due to an immunosuppressive tum
While immunotherapy holds great promise for combating cancer, the limited efficacy due to an immunosuppressive tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2bfcaa312e873e1be3ce3e3d3c82829
http://europepmc.org/articles/PMC6962042
http://europepmc.org/articles/PMC6962042
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jen-Shin Song, Chih-Chun Chang, Chien-Huang Wu, Trinh Kieu Dinh, Jiing-Jyh Jan, Kuan-Wei Huang, Ming-Chen Chou, Ting-Yun Shiue, Kai-Chia Yeh, Yi-Yu Ke, Teng-Kuang Yeh, Yen-Nhi Ngoc Ta, Chia-Jui Lee, Jing-Kai Huang, Yun-Chieh Sung, Kak-Shan Shia, Yunching Chen
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 3/30/2021, Vol. 118 Issue 13, p1-11, 11p